AU2001245641A1 - Mutations in human glutamate carboxypeptidase ii gene impacting folate metabolism, and detection of affected individuals - Google Patents

Mutations in human glutamate carboxypeptidase ii gene impacting folate metabolism, and detection of affected individuals

Info

Publication number
AU2001245641A1
AU2001245641A1 AU2001245641A AU4564101A AU2001245641A1 AU 2001245641 A1 AU2001245641 A1 AU 2001245641A1 AU 2001245641 A AU2001245641 A AU 2001245641A AU 4564101 A AU4564101 A AU 4564101A AU 2001245641 A1 AU2001245641 A1 AU 2001245641A1
Authority
AU
Australia
Prior art keywords
mutations
detection
affected individuals
glutamate carboxypeptidase
folate metabolism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001245641A
Inventor
Angela M. Devlin
Charles H. Halsted
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2001245641A1 publication Critical patent/AU2001245641A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001245641A 2000-03-13 2001-03-12 Mutations in human glutamate carboxypeptidase ii gene impacting folate metabolism, and detection of affected individuals Abandoned AU2001245641A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18898300P 2000-03-13 2000-03-13
US60188983 2000-03-13
PCT/US2001/007880 WO2001068897A2 (en) 2000-03-13 2001-03-12 Mutations in human glutamate carboxypeptidase ii gene impacting folate metabolism, and detection of affected individuals

Publications (1)

Publication Number Publication Date
AU2001245641A1 true AU2001245641A1 (en) 2001-09-24

Family

ID=22695396

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001245641A Abandoned AU2001245641A1 (en) 2000-03-13 2001-03-12 Mutations in human glutamate carboxypeptidase ii gene impacting folate metabolism, and detection of affected individuals

Country Status (3)

Country Link
US (2) US20020009734A1 (en)
AU (1) AU2001245641A1 (en)
WO (1) WO2001068897A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060024676A1 (en) * 2003-04-14 2006-02-02 Karen Uhlmann Method of detecting epigenetic biomarkers by quantitative methyISNP analysis
JP5114201B2 (en) * 2004-09-27 2013-01-09 サノフイ−アベンテイス・ドイチユラント・ゲー・エム・ベー・ハー Recombinant carboxypeptidase B
ES2404311T3 (en) * 2005-04-12 2013-05-27 454 Life Sciences Corporation Methods for determining sequence variants using ultra-deep sequencing
KR100851035B1 (en) * 2005-08-23 2008-08-11 대한민국 - - Pharmaceutical composition and composition for screening therapeutics to preventing and treating of -amyloid accumulation in brain comprising GCP-Glutamate carboxypeptidase- as an active ingredient method for screening using said composition
JP2010521156A (en) 2007-03-16 2010-06-24 ４５４ ライフ サイエンシーズ コーポレイション System and method for detection of HIV drug resistant variants
US20110008311A2 (en) * 2008-11-03 2011-01-13 The Board Of Trustees Of The University Of Illinois Animal Model and Use of 17Beta-Hydroxysteroid Dehydrogenase Type 7 in the Diagnosis of Anencephaly
KR101164645B1 (en) 2011-10-07 2012-07-20 대한민국 Pharmaceutical composition to preventing and treating of alzheimer's disease comprising gcp ii mutant
CN112961878B (en) * 2021-03-08 2023-04-25 昆明理工大学 Application of lactobacillus plantarum gene in folic acid biological generation
WO2023180103A1 (en) * 2022-03-21 2023-09-28 Immundiagnostik Ag Kit of parts and microbiological method for assessment of the folate status in serum and red blood cells

Also Published As

Publication number Publication date
WO2001068897A3 (en) 2002-04-18
US20040185487A1 (en) 2004-09-23
WO2001068897A2 (en) 2001-09-20
US20020009734A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU2002337696A1 (en) Detection of tumor rna in plasma and serum
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2001256856A1 (en) Nutritional preparation comprising ribose and folic acid and medical use thereof
AU2002223599A1 (en) Pyrimidinone derivatives and their use in the treatment of atherosclerosis
AU2002322086A1 (en) Systems and methods for trading in an exclusive market
GB2361703B (en) Folic acid and/or vitamin B12-lactoferrin complex
AU2002217393A1 (en) Educated nk t cells and their uses in the treatment of immune-related disorders
AU2001245641A1 (en) Mutations in human glutamate carboxypeptidase ii gene impacting folate metabolism, and detection of affected individuals
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2002319717A1 (en) Mutant nurr1 gene in parkinson's disease
AU2002236868A1 (en) Particle sizer and dna sequencer
AU2003255463A1 (en) Substituted isoxazole derivatives and their use in pharmaceutics
AU2003252261A1 (en) System for measuring chromaticity in visible and invisible regions
AU2001250999A1 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
WO2002083916A8 (en) Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
AU2002239256A1 (en) Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
AU2003218261A1 (en) Improvements in pharmaceutical discovery and development
WO2003085121A9 (en) Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
AU2002213145A1 (en) Detection and quantification of human herpes viruses
AU2002254079A1 (en) Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
AU2003298570A1 (en) Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof
AU2001285467A1 (en) Methods for detecting mutations in the human scurfy/foxp3 gene
AU2001230471A1 (en) Tracking gene expression and metabolic processes in subjects
AU2002345407A1 (en) Human cervical cancer 5 protooncogene and protein encoded therein
AU2003258291A1 (en) HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS